‘Biggest market share gains in my 16 years’: Dis-Chem CEO hails Better Rewards’ costly win
Dis-Chem reported 8% topline growth in the six months to 31 August, gaining significant market share with its reimagined Better Rewards programme, helped by strong demand for GLP-1 drugs.